Epic Bios develops customized therapies using its Gene Expression Modulation System (GEMS) platform, which leverages epigenomic modulators to dynamically control gene expression. This technology addresses complex diseases by providing targeted treatment options that can be tailored to specific genetic profiles.
Funding
Funding not disclosed
Founders
Product
Problem
Many complex diseases lack effective treatments due to the limitations of traditional therapies in precisely controlling gene expression. Existing methods often fail to address the dynamic and intricate nature of gene regulation, resulting in suboptimal therapeutic outcomes.
Solution
Epic Bio is developing a new class of therapeutics based on its Gene Expression Modulation System (GEMS) platform, which leverages epigenomic modulators to dynamically and precisely control gene expression. The GEMS platform offers a customizable approach to address complex diseases by creating targeted treatment options tailored to specific disease indications. By harnessing the power of the epigenome, Epic Bio aims to create new therapeutic possibilities that can overcome the limitations of current genetic medicine approaches. The platform's "mix and match" capabilities allow for the combination of various epigenomic modulators to create customized therapies.
Target Audience
The primary target audience includes patients suffering from complex diseases that are not adequately addressed by existing treatments, as well as researchers and clinicians seeking more precise and effective gene regulation therapies.
Features
- Gene Expression Modulation System (GEMS) platform for dynamic control of gene expression
- Customizable therapies tailored to specific disease indications
- Toolbox of epigenomic modulators for creating targeted treatments
- Ability to "mix and match" components for customized therapeutic solutions